{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:47:02Z","timestamp":1792504022107,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.steroids.2014.12.013","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T07:16:17Z","timestamp":1419923777000},"page":"8-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"special_numbering":"PA","title":["Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers"],"prefix":"10.1016","volume":"99","author":[{"given":"Susan B.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2014.12.013_b0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/carcin\/21.3.427","article-title":"Hormonal carcinogenesis","volume":"21","author":"Henderson","year":"2000","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.steroids.2014.12.013_b0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7827-1-73","article-title":"Estrogen, progesterone, and epithelial ovarian cancer","volume":"7","author":"Ho","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"10.1016\/j.steroids.2014.12.013_b0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.steroids.2012.11.001","article-title":"Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis","volume":"78","author":"Yue","year":"2013","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.steroids.2014.12.013_b0020","first-page":"106","article-title":"Estrogen signaling and the DNA damage response in hormone dependent breast cancers","volume":"14","author":"Caldon","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.steroids.2014.12.013_b0025","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.steroids.2014.12.013_b0030","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","article-title":"Menarche, menopause, and breast cancer risk: individual participant meta-analysis including 118,964 women with breast cancer from 117 epidemiological studies","volume":"13","year":"2012","journal-title":"Lancet Oncol"},{"issue":"20","key":"10.1016\/j.steroids.2014.12.013_b0035","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.steroids.2014.12.013_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","article-title":"Ovarian cancer: etiology, risk factors, and epidemiology","volume":"55","author":"Hunn","year":"2013","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.steroids.2014.12.013_b0045","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1023\/A:1020239211145","article-title":"Obesity, body size, and risk of postmenopausal breast cancer: the Women\u2019s Health Initiative (United States)","volume":"13","author":"Morimoto","year":"2002","journal-title":"Cancer Causes Control"},{"issue":"16","key":"10.1016\/j.steroids.2014.12.013_b0050","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jnci\/djg022","article-title":"Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women","volume":"95","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"10.1016\/j.steroids.2014.12.013_b0055","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jnci\/djg022","article-title":"Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women","volume":"95","author":"Key","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.steroids.2014.12.013_b0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"issue":"9922","key":"10.1016\/j.steroids.2014.12.013_b0065","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomized placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.steroids.2014.12.013_b0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","volume":"28","author":"Dowsett","year":"2010","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.steroids.2014.12.013_b0075","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial","volume":"11","author":"Cuzick","year":"2010","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.steroids.2014.12.013_b0080","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies","volume":"94","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.steroids.2014.12.013_b0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1025671317220","article-title":"Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin, and SHBG","volume":"14","author":"Manjer","year":"2003","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.steroids.2014.12.013_b0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjc.6601517","article-title":"Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study","volume":"90","author":"Zeleniuch-Jacquotte","year":"2004","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.steroids.2014.12.013_b0095","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1677\/erc.1.01038","article-title":"Postmenopausal serum androgens, oestrogens, and breast cancer risk: the European prospective investigation into cancer and nutrition","volume":"12","author":"Kaaks","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.steroids.2014.12.013_b0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jnci\/djn415","article-title":"Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women","volume":"101","author":"Gunter","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.steroids.2014.12.013_b0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1055-9965.EPI-08-0808","article-title":"Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort","volume":"18","author":"Sieri","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.steroids.2014.12.013_b0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/ERC-09-0211","article-title":"Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study","volume":"17","author":"Woolcott","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.steroids.2014.12.013_h0115","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1055-9965.EPI-09-0532","article-title":"Circulating steroid hormone levels and risk of breast cancer for postmenopausal women","volume":"19","author":"Baglietto","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.steroids.2014.12.013_h0120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/jnci\/djr531","article-title":"Estrogen metabolism and risk of breast cancer in postmenopausal women","volume":"104","author":"Fuhrman","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.steroids.2014.12.013_b0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10549-012-2391-z","article-title":"Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up","volume":"137","author":"Zhang","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.steroids.2014.12.013_b0125","first-page":"79","article-title":"A prospective study of endogenous hormones and breast cancer","volume":"18","author":"Helzlsouer","year":"1994","journal-title":"Cancer Detect Prev"},{"issue":"7","key":"10.1016\/j.steroids.2014.12.013_b0130","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/bjc.1997.183","article-title":"A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey","volume":"75","author":"Thomas","year":"1997","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.steroids.2014.12.013_b0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ijc.20403","article-title":"Endogenous sex hormones and subsequent breast cancer in premenopausal women","volume":"112","author":"Micheli","year":"2004","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.steroids.2014.12.013_b0140","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/bcr2779","article-title":"Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk","volume":"12","author":"Dorgan","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.steroids.2014.12.013_b0145","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/bcr3394","article-title":"Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses\u2019 Health Study II","volume":"15","author":"Fortner","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.steroids.2014.12.013_b0150","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(13)70301-2","article-title":"Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies","volume":"14","year":"2013","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.steroids.2014.12.013_b0155","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/ijc.28528","article-title":"Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status \u2013 results from the EPIC cohort","volume":"134","author":"Kaaks","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.steroids.2014.12.013_b0160","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","article-title":"Risk of endometrial cancer following estrogen replacement with and without progestins","volume":"91","author":"Weiderpass","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.steroids.2014.12.013_b0165","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"10.1016\/j.steroids.2014.12.013_b0170","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/aje\/kwq300","article-title":"Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition","volume":"172","author":"Allen","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.steroids.2014.12.013_b0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.24672","article-title":"Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses\u2019 Health Study cohort 1976\u20132004","volume":"126","author":"Karageorgi","year":"2010","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.steroids.2014.12.013_b0180","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/aje\/kws434","article-title":"Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype","volume":"177","author":"Amankwah","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.steroids.2014.12.013_b0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/1055-9965.98.14.1","article-title":"Endogenous hormones and ovarian cancer: epidemiology and current hypotheses","volume":"14","author":"Lukanova","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.steroids.2014.12.013_b0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1677\/ERC-07-0064","article-title":"Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"15","author":"Allen","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.steroids.2014.12.013_b0195","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1055-9965.EPI-07-2686","article-title":"A prospective evaluation of insulin and insulin-like growth factor I as risk factors for endometrial cancer","volume":"17","author":"Gunter","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.steroids.2014.12.013_b0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bjc.6603527","article-title":"A prospective study of postmenopausal hormone use and ovarian cancer risk","volume":"96","author":"Danforth","year":"2007","journal-title":"BJC"},{"key":"10.1016\/j.steroids.2014.12.013_b0205","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","article-title":"Million Women Study Collaborators. Ovarian cancer and hormone-replacement therapy in the Million Women Study","volume":"369","author":"Beral","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.steroids.2014.12.013_b0210","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.24086","article-title":"Body mass index and risk of ovarian cancer","volume":"115","author":"Leitzmann","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.steroids.2014.12.013_b0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2009.1052","article-title":"Hormone therapy and ovarian cancer","volume":"302","author":"M\u00f8rch","year":"2009","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.steroids.2014.12.013_b0220","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.1995.03530240036037","article-title":"Serum gonadotropins and steroid hormones and the development of ovarian cancer","volume":"274","author":"Helzlsouer","year":"1995","journal-title":"JAMA"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14003067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14003067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T06:05:10Z","timestamp":1690783510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X14003067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":45,"alternative-id":["S0039128X14003067"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.12.013","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}